Bifidobacterium Infantis Market Report – Research, Industry Analysis Reports and Market Demands

Global Bifidobacterium Infantis Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

Request for Sample of this report

Buy now

Table of Content

1 Market Overview

1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
- 1.3.1 Overview: Global Bifidobacterium Infantis Consumption Value by Type: 2020 Versus 2024 Versus 2031
- 1.3.2 0-50 billion CFU/g
- 1.3.3 50-100 billion CFU/g
- 1.3.4 ＞100 billion CFU/g
1.4 Market Analysis by Application
- 1.4.1 Overview: Global Bifidobacterium Infantis Consumption Value by Application: 2020 Versus 2024 Versus 2031
- 1.4.2 Food Additives
- 1.4.3 Medicines and Supplements
- 1.4.4 Feed Additives
- 1.4.5 Others
1.5 Global Bifidobacterium Infantis Market Size & Forecast
- 1.5.1 Global Bifidobacterium Infantis Consumption Value (2020 & 2024 & 2031)
- 1.5.2 Global Bifidobacterium Infantis Sales Quantity (2020-2031)
- 1.5.3 Global Bifidobacterium Infantis Average Price (2020-2031)

2 Manufacturers Profiles

3 Competitive Environment: Bifidobacterium Infantis by Manufacturer

3.1 Global Bifidobacterium Infantis Sales Quantity by Manufacturer (2020-2025)
3.2 Global Bifidobacterium Infantis Revenue by Manufacturer (2020-2025)
3.3 Global Bifidobacterium Infantis Average Price by Manufacturer (2020-2025)
3.4 Market Share Analysis (2024)
- 3.4.1 Producer Shipments of Bifidobacterium Infantis by Manufacturer Revenue ($MM) and Market Share (%): 2024
- 3.4.2 Top 3 Bifidobacterium Infantis Manufacturer Market Share in 2024
- 3.4.3 Top 6 Bifidobacterium Infantis Manufacturer Market Share in 2024
3.5 Bifidobacterium Infantis Market: Overall Company Footprint Analysis
- 3.5.1 Bifidobacterium Infantis Market: Region Footprint
- 3.5.2 Bifidobacterium Infantis Market: Company Product Type Footprint
- 3.5.3 Bifidobacterium Infantis Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

4.1 Global Bifidobacterium Infantis Market Size by Region
- 4.1.1 Global Bifidobacterium Infantis Sales Quantity by Region (2020-2031)
- 4.1.2 Global Bifidobacterium Infantis Consumption Value by Region (2020-2031)
- 4.1.3 Global Bifidobacterium Infantis Average Price by Region (2020-2031)
4.2 North America Bifidobacterium Infantis Consumption Value (2020-2031)
4.3 Europe Bifidobacterium Infantis Consumption Value (2020-2031)
4.4 Asia-Pacific Bifidobacterium Infantis Consumption Value (2020-2031)
4.5 South America Bifidobacterium Infantis Consumption Value (2020-2031)
4.6 Middle East & Africa Bifidobacterium Infantis Consumption Value (2020-2031)

5 Market Segment by Type

5.1 Global Bifidobacterium Infantis Sales Quantity by Type (2020-2031)
5.2 Global Bifidobacterium Infantis Consumption Value by Type (2020-2031)
5.3 Global Bifidobacterium Infantis Average Price by Type (2020-2031)

6 Market Segment by Application

6.1 Global Bifidobacterium Infantis Sales Quantity by Application (2020-2031)
6.2 Global Bifidobacterium Infantis Consumption Value by Application (2020-2031)
6.3 Global Bifidobacterium Infantis Average Price by Application (2020-2031)

7 North America

7.1 North America Bifidobacterium Infantis Sales Quantity by Type (2020-2031)
7.2 North America Bifidobacterium Infantis Sales Quantity by Application (2020-2031)
7.3 North America Bifidobacterium Infantis Market Size by Country
- 7.3.1 North America Bifidobacterium Infantis Sales Quantity by Country (2020-2031)
- 7.3.2 North America Bifidobacterium Infantis Consumption Value by Country (2020-2031)
- 7.3.3 United States Market Size and Forecast (2020-2031)
- 7.3.4 Canada Market Size and Forecast (2020-2031)
- 7.3.5 Mexico Market Size and Forecast (2020-2031)

8 Europe

8.1 Europe Bifidobacterium Infantis Sales Quantity by Type (2020-2031)
8.2 Europe Bifidobacterium Infantis Sales Quantity by Application (2020-2031)
8.3 Europe Bifidobacterium Infantis Market Size by Country
- 8.3.1 Europe Bifidobacterium Infantis Sales Quantity by Country (2020-2031)
- 8.3.2 Europe Bifidobacterium Infantis Consumption Value by Country (2020-2031)
- 8.3.3 Germany Market Size and Forecast (2020-2031)
- 8.3.4 France Market Size and Forecast (2020-2031)
- 8.3.5 United Kingdom Market Size and Forecast (2020-2031)
- 8.3.6 Russia Market Size and Forecast (2020-2031)
- 8.3.7 Italy Market Size and Forecast (2020-2031)

9 Asia-Pacific

9.1 Asia-Pacific Bifidobacterium Infantis Sales Quantity by Type (2020-2031)
9.2 Asia-Pacific Bifidobacterium Infantis Sales Quantity by Application (2020-2031)
9.3 Asia-Pacific Bifidobacterium Infantis Market Size by Region
- 9.3.1 Asia-Pacific Bifidobacterium Infantis Sales Quantity by Region (2020-2031)
- 9.3.2 Asia-Pacific Bifidobacterium Infantis Consumption Value by Region (2020-2031)
- 9.3.3 China Market Size and Forecast (2020-2031)
- 9.3.4 Japan Market Size and Forecast (2020-2031)
- 9.3.5 South Korea Market Size and Forecast (2020-2031)
- 9.3.6 India Market Size and Forecast (2020-2031)
- 9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
- 9.3.8 Australia Market Size and Forecast (2020-2031)

10 South America

10.1 South America Bifidobacterium Infantis Sales Quantity by Type (2020-2031)
10.2 South America Bifidobacterium Infantis Sales Quantity by Application (2020-2031)
10.3 South America Bifidobacterium Infantis Market Size by Country
- 10.3.1 South America Bifidobacterium Infantis Sales Quantity by Country (2020-2031)
- 10.3.2 South America Bifidobacterium Infantis Consumption Value by Country (2020-2031)
- 10.3.3 Brazil Market Size and Forecast (2020-2031)
- 10.3.4 Argentina Market Size and Forecast (2020-2031)

11 Middle East & Africa

11.1 Middle East & Africa Bifidobacterium Infantis Sales Quantity by Type (2020-2031)
11.2 Middle East & Africa Bifidobacterium Infantis Sales Quantity by Application (2020-2031)
11.3 Middle East & Africa Bifidobacterium Infantis Market Size by Country
- 11.3.1 Middle East & Africa Bifidobacterium Infantis Sales Quantity by Country (2020-2031)
- 11.3.2 Middle East & Africa Bifidobacterium Infantis Consumption Value by Country (2020-2031)
- 11.3.3 Turkey Market Size and Forecast (2020-2031)
- 11.3.4 Egypt Market Size and Forecast (2020-2031)
- 11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
- 11.3.6 South Africa Market Size and Forecast (2020-2031)

12 Market Dynamics

12.1 Bifidobacterium Infantis Market Drivers
12.2 Bifidobacterium Infantis Market Restraints
12.3 Bifidobacterium Infantis Trends Analysis
12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

13.1 Raw Material of Bifidobacterium Infantis and Key Manufacturers
13.2 Manufacturing Costs Percentage of Bifidobacterium Infantis
13.3 Bifidobacterium Infantis Production Process
13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
14.2 Bifidobacterium Infantis Typical Distributors
14.3 Bifidobacterium Infantis Typical Customers

15 Research Findings and Conclusion

16 Appendix

16.1 Methodology
16.2 Research Process and Data Source

Description

According to our (Global Info Research) latest study, the global Bifidobacterium Infantis market size was valued at US$ 46 million in 2024 and is forecast to a readjusted size of USD 69.1 million by 2031 with a CAGR of 6.1% during review period.
In this report, we will assess the current U.S. tariff framework alongside international policy adaptations, analyzing their effects on competitive market structures, regional economic dynamics, and supply chain resilience.
Bifidobacterium Infantis is a subspecies of Bifidobacterium longum infantis that mainly inhabits the intestines of human infants. Clinical studies have shown that it has a strong ability to utilize human milk oligosaccharides (HMO) contained in breast milk, which can improve the intestinal environment of healthy infants and young children. It is also known as the probiotic of the new era of HMO.
This report is a detailed and comprehensive analysis for global Bifidobacterium Infantis market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Bifidobacterium Infantis market size and forecasts, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2020-2031
Global Bifidobacterium Infantis market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2020-2031
Global Bifidobacterium Infantis market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2020-2031
Global Bifidobacterium Infantis market shares of main players, shipments in revenue ($ Million), sales quantity (Tons), and ASP (US$/Ton), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Bifidobacterium Infantis
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Bifidobacterium Infantis market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Mitushi Biopharma, Fengchen Group, Jiangsu Wecare Biotechnology Co., Ltd., Shenzhen Lefu Biotechnology Co., Ltd., Hebei Hongtao Bioengineering Co., Ltd., Shandong Junle Biotechnology Co., Ltd., Shandong Xinxiong Biotechnology Co., Ltd., Newgen Biotech, Pharm-Rx, Rajvi Enterprise, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Bifidobacterium Infantis market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
0-50 billion CFU/g
50-100 billion CFU/g
＞100 billion CFU/g
Market segment by Application
Food Additives
Medicines and Supplements
Feed Additives
Others
Major players covered
Mitushi Biopharma
Fengchen Group
Jiangsu Wecare Biotechnology Co., Ltd.
Shenzhen Lefu Biotechnology Co., Ltd.
Hebei Hongtao Bioengineering Co., Ltd.
Shandong Junle Biotechnology Co., Ltd.
Shandong Xinxiong Biotechnology Co., Ltd.
Newgen Biotech
Pharm-Rx
Rajvi Enterprise
Shandong Pingao Pharmaceutical Co., Ltd.
Shaanxi Chenming Biotechnology Co., Ltd.
Xi'an Minglang Biotechnology Co., Ltd.
Jiahe Biotechnology (Shanxi) Co., Ltd.
Shaanxi Ruimao Biotechnology Co., Ltd.
Shaanxi Baohe Biotechnology Co., Ltd.
Shaanxi Lesent Biotechnology Co., Ltd.
Shaanxi Shuoyang Biotechnology Co., Ltd.
Shaanxi Mufan Biotechnology Co., Ltd.
Xi'an An'Drong Biomedical Technology Co., Ltd.
Shaanxi Guanchen Biotechnology Co., Ltd.
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Bifidobacterium Infantis product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Bifidobacterium Infantis, with price, sales quantity, revenue, and global market share of Bifidobacterium Infantis from 2020 to 2025.
Chapter 3, the Bifidobacterium Infantis competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Bifidobacterium Infantis breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Bifidobacterium Infantis market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Bifidobacterium Infantis.
Chapter 14 and 15, to describe Bifidobacterium Infantis sales channel, distributors, customers, research findings and conclusion.

Buy now